MacroGenics Announces MGC018 Publication in Molecular Cancer Therapeutics

NEXT STORY
Cytokinetics Announces Initiation of Phase 1 Clinical Study of CK-3772271
PREV STORY
Clearside Biomedical Announces Clinical Data Presentations at The Retina Society 2020 and Publication of XIPERE™ Data in Diabetic Macular Edema in Ophthalmology Retina
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Chiesi Global Rare Diseases and Protalix BioTherapeutics Announce Launch of Expanded Access Program in the United States for Pegunigalsidase Alfa for the Proposed Treatment of Fabry Disease

author_avatar
NASDAQ Market News

Connect Biopharma Expands Executive Leadership Team with Hire of Chief Financial Officer

author_avatar
NASDAQ Market News

Zentalis Pharmaceuticals Reports Third Quarter 2020 Financial Results and Operational Update

author_avatar
NASDAQ Market News